Interventional Radionuclide Therapy of Hepatocellular Carcinoma:Assessment of Intratumoral Retention of HPMA Copolymers

To develop new radiopharmaceuticals for the interventional radionuclide therapy of recurrent hepatocellular carcinoma, poly(HPMA)-APMA-DTPA[HPMA=N-(2-hydroxypropyl) methacrylamide; APMA=N-(3-aminopro-pyl)methacrylamide; DTPA=diethylenetriaminepentaacetic acid] was synthesized by free radical precipitation polymerization in acetone/dimethylsulfoxide with N,N′-azobis(isobutyronitrile) as the initiator. The copolymers were characterized with nuclear magnetic resonance(NMR) spectroscopy and gel permeation chromatography(GPC, M_n=2.2×10⁴, M_w/M_n=1.38). Subsequently, poly(HPMA)-APMA-DTPA was conjugated with ^99mTc radionuclide. Prolonged retention of poly(HPMA)-APMA-DTPA conjugate within the tumor tissues was demonstrated by single-photon emission computed tomography computed tomography(SPECT-CT) at 1, 2, 4 and 24 h following intra-tumoral injection of the conjugate to hepatocellular carcinoma xenografts in mice. DTPA-^99mTc was also synthesized and characterized for comparison. The data suggest that the poly(HPMA)-APMA-DTPA conjugates might be useful for the interventional radionuclide therapy of recurrent hepatocellular carcinoma in humans.     

Probing the Adhesion of Hepatocellular Carcinoma HepG2 and SK‐Hep‐1 Cells

Carcinoma cell differentiation stage is an important indicator of cell behavior. For example, cell mobility is much higher for poorly‐differentiated hepatocellular carcinoma SK‐Hep‐1 cells than for well‐differentiated HepG2 cells. In this study, we have cultured HepG2 and SK‐Hep‐1 cells on chemically patterned polydimethylsiloxane (PDMS) substrates to observe differences in the adhesion properties and cell structure that occur due to the patterns. Both cell lines showed a preference for the hydrophobic regions on the patterned PDMS surface with SK‐Hep‐1 cells achieving a higher density than HepG2 for the same cell‐count solutions. Further, SK‐Hep‐1 cells adopted the square or hexagonal shape of the surface patterns while HepG2 cells maintained their more rounded shape. AFM force measurement arrays were also performed on the cell surfaces to measure and map adhesion values between the tip and cell surface membrane. These results demonstrate that, in addition to cell shape and size, adhesion expression in hepatocellular carcinoma cells is differentiation stage dependent. Further, the ability of the SK‐Hep‐1 cells to adopt the shape of the substrate pattern indicates they are more structurally labile, which may contribute to their higher mobility.     

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma

Glypican-3 (GPC3) is expressed in 75% of hepatocellular carcinoma (HCC), but not normal liver, making it a promising HCC therapeutic target. GC33 is a full-length humanized monoclonal IgG1 specific to GPC3 that can localize to HCC in vivo. GC33 alone failed to demonstrate therapeutic efficacy when evaluated in patients with HCC; however, we posit that cytotoxic functionalization of the antibody with therapeutic radionuclides, may be warranted. Alpha particles, which are emitted by radioisotopes such as Actinium-225 (Ac-225) exhibit high linear energy transfer and short pathlength that, when targeted to tumors, can effectively kill cancer and limit bystander cytotoxicity. Macropa, an 18-member heterocyclic crown ether, can stably chelate Ac-225 at room temperature. Here, we synthesized and evaluated the efficacy of [²²⁵Ac]Ac–Macropa–GC33 in mice engrafted with the GPC3-expressing human liver cancer cell line HepG2. Following a pilot dose-finding study, mice (n = 10 per group) were treated with (1) PBS, (2) mass-equivalent unmodified GC33, (3) 18.5 kBq [²²⁵Ac]Ac–Macropa–IgG1 (isotype control), (4) 9.25 kBq [²²⁵Ac]Ac–Macropa–GC33, and (5) 18.5 kBq [²²⁵Ac]Ac–Macropa–GC33. While significant toxicity was observed in all groups receiving radioconjugates, the 9.25 kBq [²²⁵Ac]Ac–Macropa–GC33 group demonstrated a modest survival advantage compared to PBS (p = 0.0012) and 18.5 kBq [²²⁵Ac]Ac–IgG1 (p = 0.0412). Hematological analysis demonstrated a marked, rapid reduction in white blood cells in all radioconjugate-treated groups compared to the PBS and unmodified GC33 control groups. Our studies highlight a significant disadvantage of using directly-labeled biomolecules with long blood circulation times for TAT. Strategies to mitigate such treatment toxicity include dose fractionation, pretargeting, and using smaller targeting ligands.     

Extraordinary NO2 Removal by the Metal–Organic Framework UiO‐66‐NH2

Here we discuss the removal of nitrogen dioxide, an important toxic industrial chemical and pollutant, from air using the MOF UiO‐66‐NH₂. The amine group is found to substantially aid in the removal, resulting in unprecedented removal capacities upwards of 1.4 g of NO₂ /g of MOF. Furthermore, whereas NO₂ typically generates substantial quantities of NO on sorbents, the amount generated by UiO‐66‐NH₂ is significantly reduced. Of particular significance is the formation of a diazonium ion on the aromatic ring of the MOF, and the potential reduction of NO₂ to molecular nitrogen.     

New Insights on Potentiometric Immunosensor at Carbon Fiber Microelectrode for Alpha-Fetoprotein in Hepatocellular Carcinoma

Herein, we investigated the analytical features of potentiometric immunosensors for detection of alpha-fetoprotein (AFP) in hepatocellular carcinoma at different electrodes, such as carbon fiber microelectrode (CFME) and carbon-disk electrode (CDE), respectively. To construct such an immunosensor, anti-AFP capture antibodies were first conjugated covalently onto the activated electrodes through typical carbodiimide coupling. Thereafter, one-step immunoreaction protocol was successfully introduced to develop a new potentiometric immunoassay upon addition of AFP. Accompanying the antigen-antibody reaction, the surface charges of the modified electrodes were changed for the readout of electric potential. Results indicated that the linear range of CDE-based immunosensor was 0.1–100 ng mL⁻¹ AFP, whereas the assay sensitivity by using CFME could be further increased to 3.2 pg mL⁻¹ with the linear range from 0.01 to 500 ng mL⁻¹ AFP. Meanwhile, CFME-based immunosensor showed high sensitivity, good reproducibility and specificity, and could be utilized for the analysis of human serum specimens with consistent results relative to commercialized ELISA kit.     

多孔骨架固定分子催化剂催化CO2加氢制备甲酸研究进展

近年来, 大气中CO₂含量急剧增加, 导致了严重的温室效应. 将CO₂作为C1资源转化为燃料或精细化学品引起了越来越多的关注. 开发高效、 稳定、 可回收利用的催化剂成为CO₂资源化利用的关键. 在众多的CO₂加氢催化剂中, 功能性多孔骨架材料固定型分子催化剂展示出优异的性能, 成为研究的热点之一. 功能性骨架材料, 如多孔有机聚合物(POPs)、 共价有机骨架(COFs)和金属有机骨架(MOFs), 具有比表面积大、 热稳定性高和可调性等特点, 在设计合成催化剂方面发挥着重要作用. 本文介绍了POPs/COFs/MOFs多孔骨架材料固定分子催化剂的开发及在催化CO₂合成甲酸领域的最新进展.     

Exploratory Study Using Urinary Volatile Organic Compounds for the Detection of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) biomarkers are lacking in clinical practice. We therefore explored the pattern and composition of urinary volatile organic compounds (VOCs) in HCC patients. This was done in order to assess the feasibility of a potential non-invasive test for HCC, and to enhance our understanding of the disease. This pilot study recruited 58 participants, of whom 20 were HCC cases and 38 were non-HCC cases. The non-HCC cases included healthy individuals and patients with various stages of non-alcoholic fatty liver disease (NAFLD), including those with and without fibrosis. Urine was analysed using gas chromatography–ion mobility spectrometry (GC–IMS) and gas chromatography–time-of-flight mass spectrometry (GC–TOF-MS). GC–IMS was able to separate HCC from fibrotic cases with an area under the curve (AUC) of 0.97 (0.91–1.00), and from non-fibrotic cases with an AUC of 0.62 (0.48–0.76). For GC-TOF-MS, a subset of samples was analysed in which seven chemicals were identified and tentatively linked with HCC. These include 4-methyl-2,4-bis(p-hydroxyphenyl)pent-1-ene (2TMS derivative), 2-butanone, 2-hexanone, benzene, 1-ethyl-2-methyl-, 3-butene-1,2-diol, 1-(2-furanyl)-, bicyclo(4.1.0)heptane, 3,7,7-trimethyl-, [1S-(1a,3β,6a)]-, and sulpiride. Urinary VOC analysis using both GC–IMS and GC-TOF-MS proved to be a feasible method of identifying HCC cases, and was also able to enhance our understanding of HCC pathogenesis.     

Post Synthetic Modification of NH2-(Zr-MOF) via Rapid Microwave-promoted Synthesis for Effective Adsorption of Pb(II) and Cd(II)

Excessive heavy metals in the water constitute a health hazard to humans, yet it may be efficiently purified using adsorbents. Herein, for the first time, UiO-66-NH₂ was modified by Glycidyl methacrylate (GMA) via microwave heating method to investigate its potential for adsorption of Pb(II) and Cd(II) metal ions. Synthesized MOF was characterized by TGA, XRD, BET, FE-SEM-EDX, and FTIR. The MOF has a huge surface area of 1144 m²/g, a mean pore diameter of 2.84 nm, and a total pore volume of 0.37 cm³/g. The effect of UiO-66-GMA performance was evaluated by investigating the impact of pH (1–9), contact time (0–200 min), initial metal ions concentration (20–1000 mg/L), temperature (25–55 °C), adsorbent dosage (0.5–3 g/L), and co existences of other metals was investigated on Pb(II) and Cd(II) percentage removal. Following an analysis of the adsorption isotherms, kinetics, and thermodynamics, the Temkin isothermal model showed an excellent fit with the adsorption data (R² = 0.99). The adsorption process was a spontaneous endothermic reaction and kinetically followed the pseudo-second-order kinetics model. Microwave heating method produced highly crystalline small Zr-MOF nanoparticles with a short reaction time. It promoted the simple yet highly efficient synthesis of Zr-based MOFs, as shown by the reaction mass space-time yield. The adsorption capability of Pb to the presence of several polar functional groups, including as primary and secondary amines, ester, alkene, and hydroxyl groups. This adsorbent is a potential candidate for wastewater treatment due to its outstanding structural stability in acidic and basic solutions, high removal efficiency, and recyclability.     

Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin

Doxorubicin (Dox) is the most widely used chemotherapeutic agent and is considered a highly powerful and broad-spectrum for cancer treatment. However, its application is compromised by the cumulative side effect of dose-dependent cardiotoxicity. Because of this, targeted drug delivery systems (DDS) are currently being explored in an attempt to reduce Dox systemic side-effects. In this study, DDS targeting hepatocellular carcinoma (HCC) has been designed, specifically to the asialoglycoprotein receptor (ASGPR). Dox-loaded albumin-albumin/lactosylated (core-shell) nanoparticles (tBSA/BSALac NPs) with low (LC) and high (HC) crosslink using glutaraldehyde were synthesized. Nanoparticles presented spherical shapes with a size distribution of 257 ± 14 nm and 254 ± 14 nm, as well as an estimated surface charge of −28.0 ± 0.1 mV and −26.0 ± 0.2 mV, respectively. The encapsulation efficiency of Dox for the two types of nanoparticles was higher than 80%. The in vitro drug release results showed a sustained and controlled release profile. Additionally, the nanoparticles were revealed to be biocompatible with red blood cells (RBCs) and human liver cancer cells (HepG2 cells). In cytotoxicity assays, Dox-loaded nanoparticles decrease cell viability more efficiently than free Dox. Specific biorecognition assays confirmed the interaction between nanoparticles and HepG2 cells, especially with ASGPRs. Both types of nanoparticles may be possible DDS specifically targeting HCC, thus reducing side effects, mainly cardiotoxicity. Therefore, improving the quality of life from patients during chemotherapy.     

Synthesis,Structural Characterization and Thermal Stability of [Mn(3‐bpd)2(NCS)2(H2O)2]·2H2O (1) and {[Mn(bpe)(NCS)2(H2O)2]·(3‐bpd)·(bpe)·H2O}n (2) from One‐Pot Crystallization

Two supramolecular architectures, [Mn(3‐bpd)₂(NCS)₂(H₂O)₂]·2H₂O ( 1 ) and {[Mn(bpe)(NCS)₂(H₂O)₂]·(3‐bpd)·(bpe)·H₂O}_n ( 2 ) [bpe = 1,2‐bis(4‐pyridyl)ethylene and 3‐bpd = 1,4‐bis(3‐pyridyl)‐2,3‐diaza‐1,3‐butadiene] have been synthesized and characterized by spectroscopic, elemental and single crystal X‐ray diffraction analyses. Compound 1 crystallizes in the monoclinic system, space group P2₁/c, with chemical formula C₂₆H₂₈Mn N₁₀O₄S₂, a = 9.1360(6), b = 9.7490(6), c = 17.776(1) Å, β = 93.212(1)°, and Z = 2 while compound 2 crystallizes in the orthorhombic system, space group P2₁2₁2₁, with chemical formula C₃₈H₃₆Mn₁N₁₀O₃S₂, a = 14.1902(6), b = 15.4569(7), c = 18.2838(8) Å, α = β = γ = 90°, and Z = 4. Structural determination reveals that the coordination geometry at Mn(II) in compound 1 or 2 is a distorted octahedral which consists of two nitrogen donors of two NCS^?ligands, two oxygen donors of two water molecules, and two nitrogen donors of two 3‐bpd ligands for 1 and two dpe ligands for 2 , respectively. The two 3‐bpd ligands in 1 adopt a monodentate binding mode and the dpe in 2 adopts a bismonodentate bridging mode to connect the Mn(II) ions forming a 1D chain‐like coordination polymer. Both the π‐π stacking interactions between the coordinated and the free pyridyl‐based ligands and intermolecular hydrogen bonds among the coordinated and the crystallized water molecules and the free pyridyl‐based ligands play an important role in construction of these 3D supramolecular architectures.     

苯乙酸对肝癌细胞系SMMC-7721的增殖抑制作用及与RNA编辑酶ADAR1表达的相关性

为探讨苯乙酸(PA)对肝癌细胞系SMMC-7721的增殖抑制作用及其与RNA编辑酶ADAR1表达的相关性, 应用细胞计数及MTT法检测了不同浓度(0.5, 1.0, 2.0和4.0 mmol/L)PA对肝癌细胞系SMMC-7721的增殖抑制作用, 通过流式细胞术(FCM)分析了各细胞周期的细胞百分比, 应用半定量逆转录-聚合酶链式反应(RT-PCR)及免疫印迹杂交分析使用不同浓度(0.5, 1.0, 2.0 mmol/L)PA作用后肝癌细胞系SMMC-7721中RNA编辑酶ADAR1 mRNA及蛋白表达的变化. 结果表明, 肝癌细胞系SMMC-7721经不同浓度PA作用后, 增殖抑制率随作用时间延长及PA浓度增加而明显提高(P<0.05), 但2.0和4.0 mmol/L PA作用72 h后组间差异比较无统计学意义(P>0.05). 肝癌细胞系SMMC-7721中RNA编辑酶ADAR1 mRNA及蛋白表达随PA浓度增加而明显降低(P<0.05). 通过沉默SMMC-7721细胞中ADAR1的表达发现, ADAR1表达下调可有效抑制肝癌细胞增殖. 结果表明, PA可阻抑肝癌细胞系SMMC-7721细胞增殖, 且存在时间及剂量的依赖性, 作用机制与PA下调ADAR1表达相关.     

Large-scale Ni-MOF derived Ni_3S_2 nanocrystals embedded in N-doped porous carbon nanoparticles for high-rate Na~+ storage

Metal organic framework(MOF) has been confirmed as the promising precursor to develop the conve rsion-typed anode mate rials of sodium-ion batteries(SIBs) because of the tunable structure design and simple functional modification.Here,we prepare the ultrasmall Ni_3S_2 nanocrystals embedded into N-doped porous carbon nanoparticles using the scalable Ni-MOF as precursor(denoted as Ni_3S_2@NPC).The ultrasmall size of Ni_3S_2 can work for accelerated electro n/ion transfer to facilitate the electrochemical reaction kinetics.Moreover,the robust conductivity network originated from N-doped porous carbon nanoparticles can not only improve the electron conductivity,but also enhance the electrode integrity and stability of the electrode/electrolyte interface.In addition,the N heteroatoms provide extra Na storage sites.Accordingly,the electrode delivers the obviously competitive capacities and high-power output with respect to the currently reported Ni_3S_2/C composites.This study provides a scalable and universal strategy to develop the advanced transition metal sulfides for practically feasible SIBs.     

柴胡逆转肝细胞癌多药耐药作用与相关机制的研究

选用对VCR天然耐药肝癌细胞株Bel-7402为对象来研究柴胡逆转MDR效果与相关的机制,以寻找一种新型的具有多药耐药逆转活性的中药.结果表明,柴胡具有逆转肝细胞癌多药耐药作用,并与抗癌药物VCR有协同作用.柴胡对人肝癌Bel-7402细胞株具有多药耐药逆转作用,提高了耐药细胞内的VCR含量,增加了VCR对细胞G2期阻滞作用,抑制了P-170糖蛋白的表达,抑制MDR1/mRNA的表达,提高了TopoαmRNA水平.     

Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of 193mPt and 195mPt Radionuclides in Auger Electron Therapy

^193mPt and ^195mPt radionuclides are therapeutically attractive Auger electron emitters with notably high Auger electron yield per decay. The present paper summarizes the first step of research on the applications of core-shell (Au@Pt) nanoparticles for electron Auger therapy of HER2+ (human epidermal growth factor receptor 2) breast cancer and hepatocellular carcinoma. Gold nanoparticles (30 nm) were synthesized covered with a platinum shell at high efficiency (>80%) and were further evaluated for in vitro studies such as binding affinity, internalization and cytotoxicity. To find the mechanism(s) responsible for platinum cytotoxicity in HepG2 cells, the platinum concentration in isolated cell nuclei and cytoplasm was determined using ICP-MS (inductively coupled plasma mass spectrometry). Lack of platinum in cell nuclei suggests that the cytotoxic effect is associated with the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). Studies carried out on the SKOV-3 cell line with the use of a synthesized targeting bioconjugate (Au@Pt-PEG-trastuzumab) revealed a high affinity of this preparation to HER2+ cells, its internalization, its placement in the perinuclear area and partial intranuclear location. The specific binding for HER2 negative cells, MDA-MB-231, was negligible and Au@Pt-PEG-trastuzumab did not enter these cells. The results obtained are promising and warrant future investigation of Auger electron therapy using ^193mPt and ^195mPt based radiopharmaceuticals.     

A Porous Zn2(abct) Framework as an Efficient Carrier for 5‐Fu Delivery and Inhibiting Human Liver Cancer Cells

The creation of effective drug delivery systems is very important in diagnosis and treatment of cancer through controlled and targeted drug delivery. They can increase bioavailability of drugs and reduce their side effects. Metal‐organic frameworks (MOFs) are alternative drug delivery systems, which are suitable for targeted drug delivery due to their adjustable pore sizes and compatibility by adding some functional groups. In this work, a new porous Zn^II‐organic framework was fabricated using a tetracarboxylic acid linker 3,3′,5,5′‐azobenzene‐tetracarboxylic acid (H₄abct), which reveals a 3D channel‐type framework with a high free pore volume. The performance of the solvent‐free samples was studied on absorbing and releasing 5‐fluorouracil (5‐Fu). Characterization methods, such as FT‐IR, PXRD, HPLC, BET measurement, and GCMC simulations, were employed to characterize the 5‐Fu loaded framework. Furthermore, anticancer properties of the MOF and drug‐loaded MOF were investigated against four human liver cancer cells (HepG2, SMMC‐7721, HuH‐7 and MHCC‐97H).     

Fast Assembly of Metal Organic Framework UiO-66 in Acid-Base Tunable Deep Eutectic Solvent for the Acetalization of Benzaldehyde and Methanol

Zirconium-based metal-organic frameworks (MOFs) have attracted extensive attention owing to their robust stability and facile functionalization. However, they are generally prepared in common volatile solvents within a long reaction time. Here, we introduced environmentally friendly, cheap, and acid-based tunable deep eutectic solvents (DESs) formed from 2-methyl imidazole (MIm) and p-toluenesulfonic acid (PTSA) which significantly accelerated the assembly of zirconium-based MOF (UiO-66) without any aggressive additives. PTSA in acidic DES and ZrOCl₂ preliminarily formed Zr(IV) oxo organic acid framework, whereas basic DES completely dissolved the ligand of UiO-66. The strong hydrogen bond effect of PTSA and MIm efficiently accelerated the linker exchange between zirconium oxo organic coordination in acidic DES and benzenedicarboxylate linker in weak basic DES within a reaction time of 2 h at 50 °C. Thus, UiO-66 was quickly assembled with small particle sizes and used as an excellent catalyst for the acetalization of benzaldehyde and methanol. Therefore, the developed synthesis approach provides a new green strategy to quickly prepare and design various structures of metal-based compounds under mild reaction conditions.     

Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges

Highlights:

• Multi tyrosine kinase inhibitors licensed for HCC treatment.
• Multi kinase inhibitors not licensed for HCC treatment.
• Inhibitors of Growth Factor Receptors.
• Small molecules acting as immunomodulators.
• Small molecules inhibiting crucial HCC pathways.
• Small molecules targeting various molecular targets.

Simple SummaryLiver cancer is one of the most common types of cancer globally. Its treatment options have been limited. Sorafenib was the most commonly used drug with patients that have advanced liver cancer. Recently, multiple new target proteins and pathways, which play a major role in the disease, have been discovered. Accordingly, researchers have designed and revealed new drugs. Some of them are FDA approved and others are under investigation in clinical trials. The aim of our systematic review is to provide an overview of these recently reported targets and compounds. This review will be useful in identifying unpopular or underrated targets, as well as designing new combination treatment strategies.AbstractAccording to data provided by World Health Organization, hepatocellular carcinoma (HCC) is the sixth most common cause of deaths due to cancer worldwide. Tremendous progress has been achieved over the last 10 years developing novel agents for HCC treatment, including small-molecule kinase inhibitors. Several small molecule inhibitors currently form the core of HCC treatment due to their versatility since they would be more easily absorbed and have higher oral bioavailability, thus easier to formulate and administer to patients. In addition, they can be altered structurally to have greater volumes of distribution, allowing them to block extravascular molecular targets and to accumulate in a high concentration in the tumor microenvironment. Moreover, they can be designed to have shortened half-lives to control for immune-related adverse events. Most importantly, they would spare patients, healthcare institutions, and society as a whole from the burden of high drug costs. The present review provides an overview of the pharmaceutical compounds that are licensed for HCC treatment and other emerging compounds that are still investigated in preclinical and clinical trials. These molecules are targeting different molecular targets and pathways that are proven to be involved in the pathogenesis of the disease.     

Voltammetric Determination of 2′‐Deoxyadenosine and Adenine in Urine of Patients with Hepatocellular Carcinoma Using Fullerene‐C60‐modified Glassy Carbon Electrode

A fullerene‐C₆₀‐modified glassy carbon electrode has been examined for the simultaneous determination of 2′‐deoxyadenosine (2′‐dAdo) and adenine in human blood and urine using Osteryoung square‐wave voltammetry (OSWV) at pH 7.2. Compared to bare glassy carbon electrode (GCE), the modified electrode displays a shift of the oxidation potential in the negative direction with significant increase in the peak current for both the analytes. At modified electrode well‐defined anodic peaks at potential of 1248 mV and 994 mV are observed for 2′‐dAdo and adenine respectively. Linear calibration curves were obtained within the concentration range 10 nM to 100 μM for both the compounds in 0.1 M phosphate buffer solution (PBS) with the limit of detection 0.8×10^?8 M and 0.95×10^?8 M for 2′‐dAdo and adenine respectively. The analytical utility of the present method is demonstrated by quantitative detection of 2′‐dAdo and adenine in human urine of normal subjects as well as in patients with hepatocellular carcinoma. Interfering effect of some coexisting metabolites has also been reported.     

MOF衍生碳基电催化剂限域催化O2还原和CO2还原反应

化石燃料的大量消耗和环境的逐渐恶化导致迫切需要开发和探索有效的能源转换和存储技术. 电化学是各种能源转换装置的基础和关键. 设计和合成具有高催化活性的非贵金属基和非金属基催化剂是最好的选择. 金属有机骨架(MOF)衍生的碳基材料具有比表面积大、 孔隙率高的特点, 可以选择性地限制不同类型的金属. 因此, MOF衍生碳作为催化剂载体使用时具有良好的限域效应, 有利于提高催化剂的活性和稳定性. 本文综合评述了MOF衍生材料在催化反应中的限域效应, 并介绍了MOF衍生碳基材料在氧还原反应(ORR)和二氧化碳还原反应(CO₂RR)电催化方面的最新进展, 揭示了MOF碳基材料在电催化反应中的构效关系. 最后, 讨论了MOF衍生的碳基材料在ORR和CO₂RR电催化中的挑战和机遇, 以及未来可能的解决方案.     

MOF-derived ZnCo2O4/C wrapped on carbon fiber as anode materials for structural lithium-ion batteries

In this work, large area MOF-derived ZnCo₂O₄/C anchored on carbon fiber as high-performance anode materials was fabricated via a facile method and subsequent annealing treatment.